Cag

Cag is a long-acting amylin analogue being developed as a potential treatment for obesity. Amylin is a hormone co-secreted with insulin by the pancreas that helps regulate appetite and food intake. Cag works by mimicking amylin’s effects, promoting a feeling of fullness (satiety) and reducing food consumption. Its extended duration of action allows for once-weekly dosing, offering a convenient option for weight management in individuals with obesity or related metabolic conditions.

View Licenses

Research-Based Only